LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) › Operating Cash FlowLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: $7.48M2011: $14.47M2012: $22.18M2013: $21.23M2016: $20.76M2017: $29.84M2018: $19.78M2019: $16.02M2020: -$17.04M2021: $16.47M2022: -$22.59M2023: -$17.44M2024: $257.0K2025: -$206.0K-$206.0K2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$206.0K-180.2%2024$257.0K+101.5%2023-$17.44M+22.8%2022-$22.59M-237.2%2021$16.47M+196.7%2020-$17.04M-206.4%2019$16.02M-19.0%2018$19.78M-33.7%2017$29.84M+43.7%2016$20.76M—2013$21.23M-4.3%2012$22.18M+53.3%2011$14.47M+93.4%2010$7.48M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share